
Prescription Drug Name:
Potassium Chloride in Sodium Chloride Injection, USP, in Plastic Container, VIAFLEX Plus Container
ID:
5ab0219a-78af-4911-a982-1bafc97db420
Code:
34391-3
DESCRIPTION
id: c017f325-101f-479d-b2cb-db82912b2313
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3
|
|
|
|
|
|
|||
|
|
|
|
|
||||
0.45% Sodium Chloride Injection, USP |
|
|
|
|
|
|
|
|
0.9% Sodium Chloride Injection, USP |
|
|
|
|
|
|
|
|
0.9% Sodium Chloride Injection, USP |
|
|
|
|
|
|
|
|
CLINICAL PHARMACOLOGY
id: ffd08eee-9d34-482a-b5e4-75191572ae86
displayName: CLINICAL PHARMACOLOGY SECTION
FDA Article Code: 34090-1
INDICATIONS AND USAGE
id: 8d2b7e4d-bbbe-46c3-b7f3-ee4b9c488a05
displayName: INDICATIONS & USAGE SECTION
FDA Article Code: 34067-9
CONTRAINDICATIONS
id: ac3ee575-508c-4433-b1ea-6cb44f756b04
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3
WARNINGS
id: 26c09200-71ec-45f4-80a4-c8ab1a54f7c2
displayName: WARNINGS SECTION
FDA Article Code: 34071-1
PRECAUTIONS
id: 10d1a4a6-0caa-4ed7-8457-f128ecfeb79d
displayName: PRECAUTIONS SECTION
FDA Article Code: 42232-9
ADVERSE REACTIONS
id: 3f06870d-202e-410f-abd7-ce08fbdb98a6
displayName: ADVERSE REACTIONS SECTION
FDA Article Code: 34084-4
DOSAGE AND ADMINISTRATION
id: 20b1001d-f385-4b8f-b904-ee62ba1aa074
displayName: DOSAGE & ADMINISTRATION SECTION
FDA Article Code: 34068-7
HOW SUPPLIED
id: 6e1565f4-919c-4670-b31a-3a36e4a6c6fa
displayName: HOW SUPPLIED SECTION
FDA Article Code: 34069-5
|
|
|
|
|
|
|
0.45% Sodium Chloride Injection, USP |
|
|
|
0.9% Sodium Chloride Injection, USP |
|
|
|
0.9% Sodium Chloride Injection, USP |
DIRECTION FOR USE OF VIAFLEX PLUS PLASTIC CONTAINER
id: b8d50d42-9660-4520-9ade-4caf0a0cc2b9
displayName: SPL UNCLASSIFIED SECTION
FDA Article Code: 42229-5
PACKAGE LABELING – PRINCIPLE DISPLAY PANEL
id: 017e5bef-61df-4d2d-b6c8-7000cb124531
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4
NDC 0338-0704-34
Potassium Chloride
150 mg POTASSIUM CHLORIDE USP pH 5.5 (3.5 TO 6.5)
mEq/L SODIUM 77 POTASSIUM 20 CHLORIDE 97
NONPYROGENIC SINGLE DOSE CONTAINER ADDITIVES MAY BE
INCOMPATIBLE CONSULT WITH PHARMACIST IF AVAILABLE WHEN
INTRODUCING ADDITIVES USE ASEPTIC TECHNIQUE MIX
THOROUGHLY DO NOT STORE USUAL DOSAGE INTRAVENOUSLY
AS DIRECTED BY A PHYSICIAN SEE DIRECTIONS CAUTIONS
SQUEEZE AND INSPECT INNER BAG WHICH MAINTAINS PRODUCT
STERILITY DISCARD IF LEAKS ARE FOUND MUST NOT BE USED
IN SERIES CONNECTIONS DO NOT USE UNLESS SOLUTION IS
CLEAR
AT ROOM TEMPERATURE (25°C/77°F) UNTIL READY TO USE
AVOID EXCESSIVE HEAT SEE INSERT
BAXTER INTERNATIONAL INC
DEERFIELD IL 60015 USA
1-800-933-0303
0.45% SODIUM CHLORIDE INJ
XXXXX
(17) YYMM00 (10) XXXXX
XXXXX
(01) 50303380704342
NDC 0338-0691-04
DIN 00786209
150 mg POTASSIUM CHLORIDE USP pH 5.5 (3.5 TO 6.5)
mEq/L SODIUM 154 POTASSIUM 20 CHLORIDE 174
OSMOLARITY 348 mOsmol/L (CALC) STERILE
NONPYROGENIC SINGLE DOSE CONTAINER ADDITIVES MAY BE
INCOMPATIBLE CONSULT WITH PHARMACIST IF AVAILABLE
WHEN INTRODUCING ADDITIVES USE ASEPTIC TECHNIQUE MIX
THOROUGHLY DO NOT STORE DOSAGE INTRAVENOUSLY AS
DIRECTED BY A PHYSICIAN SEE DIRECTIONS CAUTIONS
SQUEEZE AND INSPECT INNER BAG WHICH MAINTAINS PRODUCT
STERILITY DISCARD IF LEAKS ARE FOUND MUST NOT BE USED
IN SERIES CONNECTIONS DO NOT USE UNLESS SOLUTION IS
CLEAR
OVERWRAP AT ROOM TEMPERATURE (25°C/77°F) UNTIL READY
TO USE AVOID EXCESSIVE HEAT SEE INSERT
BAXTER VIAFLEX AND PL 146 ARE TRADEMARKS OF
BAXTER INTERNATIONAL INC
MADE IN USA
BAXTER CORPORATION
TORONTO ONTARIO CANADA
0.9% SODIUM CHLORIDE INJ
XXXXX
(17) XXXXX (10) XXXXX
XXXXX
(01) 50303380691048
NDC 0338-0695-04
DIN 00786217
300 mg POTASSIUM CHLORIDE USP pH 5.5 (3.5 TO 6.5)
mEq/L SODIUM 154 POTASSIUM 40 CHLORIDE 194
OSMOLARITY 388 mOsmol/L (CALC) STERILE
NONPYROGENIC SINGLE DOSE CONTAINER ADDITIVES MAY BE
INCOMPATIBLE CONSULT WITH PHARMACIST IF AVAILABLE
WHEN INTRODUCING ADDITIVES USE ASEPTIC TECHNIQUE MIX
THOROUGHLY DO NOT STORE DOSAGE INTRAVENOUSLY AS
DIRECTED BY A PHYSICIAN SEE DIRECTIONS CAUTIONS
SQUEEZE AND INSPECT INNER BAG WHICH MAINTAINS PRODUCT
STERILITY DISCARD IF LEAKS ARE FOUND MUST NOT BE USED
IN SERIES CONNECTIONS DO NOT USE UNLESS SOLUTION IS
CLEAR
OVERWRAP AT ROOM TEMPERATURE (25°C/77°F) UNTIL READY
TO USE AVOID EXCESSIVE HEAT SEE INSERT
BAXTER VIAFLEX AND PL 146 ARE TRADEMARKS OF
BAXTER INTERNATIONAL INC
MADE IN USA
BAXTER CORPORATION
TORONTO ONTARIO CANADA
0.9% SODIUM CHLORIDE INJ
XXXXX
(17) YYMM00 (10) XXXXX
XXXXX
(01) 50303380695046